DK167734B1 - Tiaminsaltgranulat, fremgangsmaade til fremstilling deraf samt tabletter vundet ud fra granulatet - Google Patents

Tiaminsaltgranulat, fremgangsmaade til fremstilling deraf samt tabletter vundet ud fra granulatet Download PDF

Info

Publication number
DK167734B1
DK167734B1 DK452185A DK452185A DK167734B1 DK 167734 B1 DK167734 B1 DK 167734B1 DK 452185 A DK452185 A DK 452185A DK 452185 A DK452185 A DK 452185A DK 167734 B1 DK167734 B1 DK 167734B1
Authority
DK
Denmark
Prior art keywords
thiamine
weight
granulate
binder
thiamine salt
Prior art date
Application number
DK452185A
Other languages
Danish (da)
English (en)
Other versions
DK452185D0 (da
DK452185A (da
Inventor
Nobuyuki Kitamori
Masaya Maeno
Seiji Izuhara
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK452185D0 publication Critical patent/DK452185D0/da
Publication of DK452185A publication Critical patent/DK452185A/da
Application granted granted Critical
Publication of DK167734B1 publication Critical patent/DK167734B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK452185A 1984-10-09 1985-10-04 Tiaminsaltgranulat, fremgangsmaade til fremstilling deraf samt tabletter vundet ud fra granulatet DK167734B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21234584 1984-10-09
JP59212345A JPH0753663B2 (ja) 1984-10-09 1984-10-09 チアミン塩の顆粒，その製造法および錠剤

Publications (3)

Publication Number Publication Date
DK452185D0 DK452185D0 (da) 1985-10-04
DK452185A DK452185A (da) 1986-04-10
DK167734B1 true DK167734B1 (da) 1993-12-13

Family

ID=16620997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452185A DK167734B1 (da) 1984-10-09 1985-10-04 Tiaminsaltgranulat, fremgangsmaade til fremstilling deraf samt tabletter vundet ud fra granulatet

Country Status (11)

Country Link
US (1) US4702919A (zh)
EP (1) EP0178138B1 (zh)
JP (1) JPH0753663B2 (zh)
KR (1) KR930001831B1 (zh)
CN (1) CN1012662B (zh)
AU (1) AU593223B2 (zh)
CA (1) CA1279014C (zh)
DE (1) DE3583572D1 (zh)
DK (1) DK167734B1 (zh)
HK (1) HK137693A (zh)
NZ (1) NZ213746A (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
JP2689458B2 (ja) * 1988-02-09 1997-12-10 武田薬品工業株式会社 粒状ないし粉末状のビタミンｂ▲下１▼▲下２▼類含有組成物
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
JP3011752B2 (ja) * 1990-10-23 2000-02-21 フロイント産業株式会社 徐放性製剤およびその製造方法
US5114720A (en) * 1990-12-27 1992-05-19 American Cyanamid Company Gelatin coated tablets and method for producing same
JPH05202039A (ja) * 1991-09-19 1993-08-10 Takeda Chem Ind Ltd チアミン塩酸塩結晶の製造法
AU1193092A (en) * 1992-01-10 1993-08-03 Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki Granulated pharmaceutical composition and method of obtaining it
WO1996033987A1 (en) * 1995-04-26 1996-10-31 Henkel Corporation Method of producing a tocopherol product
JP4098376B2 (ja) * 1996-09-05 2008-06-11 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
KR20080039400A (ko) 2005-07-07 2008-05-07 파남 컴퍼니스 인크. 고수용성 약물의 서방성 약학 조성물
US20070092546A1 (en) * 2005-10-24 2007-04-26 Violet Fire, Llc Thiamin based insect repellant
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5897916B2 (ja) * 2012-01-31 2016-04-06 アサヒフードアンドヘルスケア株式会社 ビタミン含有錠剤及びその製造方法
CN102988300A (zh) * 2012-12-03 2013-03-27 华中药业股份有限公司 硝酸硫胺颗粒及其制备方法
CN105520841A (zh) * 2014-10-23 2016-04-27 华中药业股份有限公司 一种二硫硫胺颗粒剂及其制备方法
WO2019145926A1 (en) * 2018-01-29 2019-08-01 Fortune Pharmacal Company Limited Stable thiamine containing pharmaceutical formulations
EP3650011A1 (en) * 2018-11-09 2020-05-13 Bio Minerals NV Water soluble silicon-containing granulate
WO2023145870A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物及び製剤並びに製剤用組成物の製造方法
WO2023145868A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物及び製剤並びに製剤用組成物の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540253A (en) * 1949-02-08 1951-02-06 Merck & Co Inc Granulation process
DE1224878B (de) * 1963-05-31 1966-09-15 Merck Ag E Verfahren zur Herstellung haltbarer und geruchloser Vitamin B-Zubereitungen
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
IT969356B (it) * 1971-10-01 1974-03-30 Kaller S Dispositivo di chiusura a tenuta
FR2202653A1 (en) * 1972-10-17 1974-05-10 Scient Feed Labo Co Granulation of unstable materials - for feedstuffs and feed premixes
IL43853A0 (en) * 1973-02-16 1974-03-14 Sparamedica Ag Pharmaceutical compositions and their manufacture
ES438635A1 (es) * 1974-06-24 1977-02-16 Shinetsu Chemical Co Procedimiento para el revestimiento de moldes solidos de do-sificacion.
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
US4486435A (en) * 1983-05-16 1984-12-04 Basf Wyandotte Corporation Spray-dried vitamin powders using hydrophobic silica

Also Published As

Publication number Publication date
CN1012662B (zh) 1991-05-29
KR930001831B1 (ko) 1993-03-15
EP0178138A3 (en) 1987-11-04
CN85107365A (zh) 1986-10-01
JPH0753663B2 (ja) 1995-06-07
EP0178138B1 (en) 1991-07-24
AU593223B2 (en) 1990-02-08
HK137693A (en) 1993-12-24
NZ213746A (en) 1988-06-30
JPS6191118A (ja) 1986-05-09
EP0178138A2 (en) 1986-04-16
DE3583572D1 (de) 1991-08-29
KR860003017A (ko) 1986-05-19
DK452185D0 (da) 1985-10-04
DK452185A (da) 1986-04-10
AU4817585A (en) 1986-04-17
CA1279014C (en) 1991-01-15
US4702919A (en) 1987-10-27

Similar Documents

Publication Publication Date Title
DK167734B1 (da) Tiaminsaltgranulat, fremgangsmaade til fremstilling deraf samt tabletter vundet ud fra granulatet
JP6564720B2 (ja) Ｄｐｐｉｖインヒビター製剤
US4950484A (en) Pharmaceutical tablet, pharmaceutical granulate and process for their preparation
DK167339B1 (da) Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf
RU2398586C2 (ru) Фармацевтическая композиция
JP4077803B2 (ja) 多孔質アパタイト粒状物を用いる安定で、味覚をマスクした製薬剤形
JP2939262B2 (ja) 製薬顆粒剤
NZ564102A (en) Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine
EP0301006B1 (en) Methylprednisolone/sodium carboxymethyl starch tablet composition
CA2067733C (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
KR20010090830A (ko) 코팅된 과립 결정성 이부프로펜 입자
CN1882321B (zh) 包含盐酸文拉法辛的小丸
CA2634006C (en) Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine
KR101197277B1 (ko) 경구용 결핵의 치료용 또는 예방용 고형 제형
CA2223281A1 (en) Alkalinizing potassium salt controlled release preparations
TR202014694A1 (tr) Eltrombopag olami̇n i̇çeren bi̇r kati oral farmasöri̇k formülasyon
JPH08310969A (ja) 固形薬品組成物及びその製造方法
CN113876735B (zh) 一种利鲁唑微球制剂及其制备方法
EP1300160B1 (en) Method of stabilizing preparation
AU665678B2 (en) Aminoguanidine spray drying process
CN114340601A (zh) 掩盖了令人不快的味道的颗粒剂及其制造方法
CN112057427A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
CA3048968A1 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
JP2006131673A (ja) 徐放化組成物及びその製造方法
JPH06345649A (ja) イプサピロン薬剤組成物

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired